Form 4 for DOC Healthpeak Properties
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001628280-23-002450 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-06 | 2023-02-02 | DOC | Bohn Scott R | CDO, Co-Head of LS | A - Grant | $0.00 | +38.1K | 62.0K | +159% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | A | A | 5,286 | $0.00 | 29,196 | D | — | — | (F1) Represents performance-based restricted stock units previously granted to the reporting person by the Company on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Compensation and Human Capital Committee (the "Compensation Committee") on February 2, 2023 (the "Determination Date"), resulting in one-third (1/3) of the shares subject to the award vesting on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued employment with the Company through the applicable vesting date. (F2) Each restricted stock unit represents the right to receive one share of common stock, subject to the applicable vesting schedule. |
| 2 | Common | Common Stock | 2023-02-02 | A | A | 21,905 | $0.00 | 51,101 | D | — | — | (F3) Represents performance-based restricted stock units previously granted to the reporting person by the Company on April 28, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Compensation Committee on the Determination Date, resulting in one-fifth (1/5) of the shares subject to the award vesting on each of the second, third, fourth, fifth and sixth anniversaries of the grant date, subject to the reporting person's continued employment with the Company through the applicable vesting date. (F2) Each restricted stock unit represents the right to receive one share of common stock, subject to the applicable vesting schedule. |
| 3 | Common | Common Stock | 2023-02-02 | A | A | 10,872 | $0.00 | 61,973 | D | — | — | (F4) Represents performance-based restricted stock units previously granted to the reporting person by the Company on October 26, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Compensation Committee on the Determination Date, resulting in one-third (1/3) of the shares subject to the award vesting on each of April 28, 2023, April 28, 2024, and April 28, 2025, subject to the reporting person's continued employment with the Company through the applicable vesting date. (F2) Each restricted stock unit represents the right to receive one share of common stock, subject to the applicable vesting schedule. |